Article 25 Jun 2024 Final Rule On Cannabis Rescheduling Could Publish In Fall 2024, Sklamberg Says United States Cannabis
Article 29 May 2024 The Rescheduling Of Cannabis: What It Means, Next Steps, And Implications For Industry United States Cannabis
Article 16 May 2024 Sklamberg Discusses Cannabis Rescheduling On NPR's 1A Podcast United States Cannabis
Article 16 Apr 2024 FDA Publishes Final Guidance On Reporting Listed Drug Amounts United States Healthcare
Article 16 Feb 2024 FDA Issues Final Rule To More Closely Align FDA Medical Device Quality System Requirements With International Consensus Standard ISO 13485 United States Healthcare
Article 26 Jan 2024 Scientific Evidence For Cannabis Rescheduling Difficult To Challenge, Says Sklamberg United States Cannabis
Article 11 Jan 2024 FDA Authorizes Florida's Plan Under FD&C Act Section 804 To Import Prescription Drugs From Canada Worldwide Healthcare
Article 03 Nov 2023 FDA Announces Draft Guidance To Continue Implementing Remote Interactive Evaluations Of Drug Manufacturing Establishments And Biomedical Research United States Healthcare
Article 31 Aug 2023 Reschedule Or Deschedule? Sklamberg Predicts Rescheduling Of Cannabis In Mindset Value Podcast United States Cannabis
Article 21 Aug 2023 HHS Takes An Important Step To Form A Biopharmaceutical Manufacturing Preparedness Consortium To Expand Domestic Biopharmaceutical Manufacturing Capability United States Healthcare